AXS-05A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in Adults

Sponsor:

Axsome Therapeutics, Inc.

Code:

NCT07766655

Conditions

Smoking Cessation

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

AXS-05 (dextromethorphan-bupropion)

Bupropion

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-01. This information was provided to ClinicalTrials.gov by Axsome Therapeutics, Inc. on 2026-08-14.